Breech presentation at term gestation Pregnancy and Childbirth Maternal care for known or suspected malpresentation of fetus
Conditions
Interventions
Participants were randomised to treatment with 10 milligram oral nifedipine tablet and subcutaneous saline placebo injection or oral placebo tablet and subcutaneous 250 microgram terbutaline injection
Sponsors
University of Malaya Medical Centre (Malaysia)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Breech presentation or transverse lie 2. Viable, singleton pregnancy 3. Gestation age 36 to 41 weeks 4. Intact membranes 5. Not in established labour
Exclusion criteria
Exclusion criteria: 1. Known gross foetal anomaly 2. Severe hypertension 3. Intrauterine growth restriction 4. Oligohydramnios 5. Antepartum haemorrhage within last 3 months 6. Uterine scar from any source 7. Known allergy to nifedipine or terbutaline 8. Other potential obstetric indication for Caesarean delivery 8.1. Placenta praevia 8.2. Suspected macrosomia >4 kg 8.3. Uterine anomaly 8.4. Obstructive pelvic tumour
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Successful version to cephalic presentation 2. Caesarean delivery | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Cephalic presentation at birth 2. Post-ECV cardiotocographic anomalies 3. Visual analogue scale satisfaction score with ECV procedure 4. Onset of labour 5. Neonatal outcome 6. Survey on patient preference of oral vs injection mode of medication 7. Maternal peri-delivery blood loss 8. Indication for operative delivery 9. Adverse drug events | — |
Countries
Malaysia
Outcome results
None listed